Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nicolae TestemitanufiledCriticalUniv Nicolae Testemitanu
Priority to MDA20010032ApriorityCriticalpatent/MD1780G2/en
Publication of MD1780F1publicationCriticalpatent/MD1780F1/en
Publication of MD1780G2publicationCriticalpatent/MD1780G2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Medicines Containing Plant Substances
(AREA)
Abstract
The invention relates to medicine, namely to hepatology. Summary of the invention consists in that concomitantly with the administration of hepatoprotectors and vitamins, the patients with hepatic cirrhosis are additionally administered during 27...35 days losartan for 0,0125...0,025 g one time a day per os.Claims: 1
MDA20010032A2001-02-022001-02-02Method of treatment of patients with hepatic cirrhosis
MD1780G2
(en)
Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body
Use of N-acetylcysteine for the preparation of a medicament suitable for the intravenous administration to prevent oxidative stress in dialysed patients